🔥 Friday 30 January 2026 Fri, 30 Jan 2026

Australian Strategic Materials reports a significant 75% jump in NdFeB alloy deliveries at its Korean Metals Plant and advances heavy rare earth production, while announcing a transformative acquisition offer from Energy Fuels Inc.

Carnaby Resources has reported a 10% increase in its Greater Duchess Copper Gold Project resource, completed full ownership of the JV, and is advancing its pre-feasibility study with strong cash backing and promising drill results.

Nine Entertainment Co. is reshaping its media portfolio with the acquisition of QMS Media, the sale of its radio assets, and a regional TV affiliate deal, aiming to boost digital revenue to over 60% by FY27.

Orion Minerals is finalising a major financing and offtake agreement with Glencore, advancing its transition to a mining company with first copper and zinc concentrate expected by late 2026.

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

RMA Global Limited has rebranded RateMyAgent to Renowned, integrating Curated Social to enhance its real estate marketing platform. The company’s strategic pivot in the US is paying off with record brokerage deals and strong revenue growth.

Felix Gold has transitioned from exploration to development with a metallurgical breakthrough producing military-grade antimony and is advancing pilot plant operations and government funding applications to meet US military demand.

Lotus Resources reports steady progress at its Kayelekera uranium mine despite supply challenges, while its Letlhakane project shows promising metallurgical advances. The company targets full production and first shipments in the second quarter of 2026.

Magnum Mining & Exploration has accelerated its rare earth elements (REE) exploration with new drilling programs in Brazil and the acquisition of the Wet Mountains REE Project in Colorado, backed by a $7 million capital raise.

Murray Cod Australia Ltd reported a robust 61% increase in sales volume and secured key certifications in Q2 FY26, while navigating operational challenges and expanding its distribution footprint.

Resmed Inc. posted robust Q2 FY2026 results, with revenue climbing 11% to $1.4 billion and a 16% rise in non-GAAP earnings per share, underpinned by strong global demand and operational efficiencies.

AdAlta Limited has launched its 'East to West' cellular immunotherapy operations through a strategic collaboration with Shanghai Cell Therapy Group to co-develop BZDS1901, an innovative CAR-T therapy targeting mesothelioma and other solid cancers. The company also strengthened its balance sheet by raising $2.8 million via private placements and repaying key investment agreements.

Galilee Energy has secured the Zydeco Gas Project in Louisiana and raised $6.5 million to fast-track development, marking a pivotal shift towards becoming a mid-tier US gas producer.

Fluence Corporation Limited has reported a robust FY 2025 with a 52.3% revenue increase and record new orders, driven by a strategic pivot to higher-margin Smart Product Solutions and recurring revenue streams.

WhiteHawk Limited reported steady Q4 revenue and advanced multiple government and academic contracts in the US and Australia, underpinning its growth in cybersecurity services.

TrivarX Limited has expanded its diagnostic portfolio by acquiring the Stabl-Im brain cancer imaging technology and reported strong clinical trial results validating its single-lead ECG algorithm for depression screening in US veterans.

Titomic has made significant strides in transitioning from development to production, securing key contracts in defense and semiconductor sectors while maintaining a strong cash position.

Lake Resources NL reported a solid quarter ending December 2025, progressing regulatory approvals for its Kachi Lithium Brine Project while slashing cash outgoings by 45% year-on-year and maintaining strong liquidity amid a sharp lithium price rally.

Fluence Corporation reported robust revenue and EBITDA growth in FY 2025, driven by strong contributions from its Ivory Coast project and expanding Smart Product Solutions. Leadership changes aim to accelerate growth as the company eyes continued momentum in 2026.

Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.

Critical Resources Limited has significantly expanded its Mavis Lake Lithium Project in Ontario and progressed gold exploration in New Zealand, while securing exclusive rights to evaluate cutting-edge solid-state battery technology.

Carma Limited has reported a surge in vehicle sales and revenue in its latest quarterly report, alongside a successful $100 million IPO that strengthens its growth trajectory.

xReality Group Limited has reported its strongest quarter yet, with record cash receipts and a doubling sales pipeline, underpinned by major US defence contracts and expanded production capacity.

Sovereign Metals has successfully recovered a high-value heavy rare earth concentrate from its Kasiya project in Malawi, while securing a strategic collaboration with the World Bank’s IFC to underpin sustainable development and financing.